Professor Fengying Wu

Professor Fengying Wu

Department of Oncology, Shanghai Pulmonary Hospital & Thoracic Cancer Institute, Tongji University School of Medicine, Shanghai, China

Dr. Fengying Wu is an associate professor at the Medical School of Tongji University's Department of Oncology, currently based at the Shanghai Pulmonary Hospital. She completed her postgraduate studies at Fudan University, and received her MD and PhD degrees from Tongji University. Dr. Wu completed her residency and fellowship in oncology at the Shanghai Pulmonary Hospital. She has been an associate professor at Tongji University since 2018 and has mentored postgraduate students and oncology fellows for several years.

Dr. Wu is involved in several phase II and phase III clinical trials for lung cancer, including the Camel, Camel-sq, Alesia, and Keynote-033 studies. She has also conducted several translational studies, with a focus on single-cell analysis in advanced lung cancer.

Dr. Wu has published over 25 articles in respected medical journals such as The Lancet Respiratory Medicine, Journal of Clinical Oncology, Nature Communications, Oncogenes, and Cancer Communications. Currently, she serves as the office director of the Lung Cancer Special Committee of the Chinese Primary Health Care Foundation, Vice Chairman of the Youth Committee of the Cancer Branch of the Shanghai Medical Association, and a member of the Standing Committee of Lung Cancer of the Chinese Elderly Health Care Association. Dr. Wu has won several awards, including the Mentorship Award of the IASLC and the First Prize of the Science and Technology Award of the Chinese Anti-Cancer Association (ranked 10th).

Updated 19 September 2023